As our understanding of the control of vasculogenesis and angiogenesis cont
inues to grow, we will be confronted with an increasing number of interacti
ng and intersecting receptor-mediated signaling pathways. if we are to be s
uccessful in developing new and novel effective therapeutic reagents that c
an function as stimulators or inhibitors of these critically important proc
esses, we will have to develop a sophisticated, full understanding of the c
omplex interactions associated with ephrin-based and metalloprotease-based
signaling pathways.